Conversely, the role of intensive insulin therapy in patients with severe sepsis is uncertain, because the beneficial effects of insulin may be overcome by the increased risk of serious adverse events related to hypoglycemia [66]. The gene discussed is INS; the disease is Hypoglycemia.